Valeo Pharma (TSE:VPH) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Valeo Pharma Inc. has initiated restructuring proceedings under the Companies’ Creditors Arrangement Act with the aim of exploring strategic alternatives and maximizing returns. The company has received court approval for protection and appointed Ernst & Young Inc. as the Monitor to assist in restructuring. Valeo Pharma has also secured interim financing to maintain operations and is committed to a swift and effective restructuring process.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.